Top

BMC Infectious Diseases

Published in:

Open Access 01-12-2023 | Thrombocytopenia | Research

Serum mAST/ALT ratio had high predictive value for adverse outcome of severe fever with thrombocytopenia syndrome with severe condition

Authors: Li Wang, Youde Liu, Renliang Qu, Zhiqiang Zou

Published in: BMC Infectious Diseases | Issue 1/2023

Abstract

Background

Severe fever with thrombocytopenia syndrome (SFTS) usually demonstrates multi-organ injury with a high mortality rate. This study aimed to investigate associations of serum aspartate/alanine aminotransferase (AST)/ALT, cytosolic AST (cAST)/ALT and mitochondrial AST (mAST)/ALT ratios with the prognosis of SFTS patients.

Methods

A total of 355 confirmed SFTS patients were included. Clinical and laboratory data were compared between survivors and nonsurvivors. Logistic regression analysis was used to assess the independent risk factors for fatality in all patients and those admitted to the intensive care unit (ICU). The predictive values of the risk factors and constructed risk models were evaluated.

Results

Mean age and biochemical parameters were significantly greater in nonsurvivors than in survivors. In ICU patients, the three ratios, high-sensitivity troponin I (hsTnI), creatine kinase (CK), lactate dehydrogenase (LDH) and α-hydroxybutyrate dehydrogenase (α-HBDH) were elevated markedly in nonsurvivors than in survivors. Multivariate logistic regression analysis showed that age, three ratios and α-HBDH were independent risk factors for mortality in all patients. Only the three ratios were independent risk factors for death in ICU patients. Risk Models (M1, M2 and M3) and simplified models (sMs) containing the three ratios respectively had comparatively high predictive values for fatality in all patients with area under ROC curves (AUCs) > 0.85. In ICU patients, mAST/ALT ratio had the highest predictive value, sensitivity and odds ratio (OR) for mortality among three ratios.

Conclusion

AST/ALT, cAST/ALT and mAST/ALT ratios were associated with unfavorable clinical outcome of SFTS. The prognostic value of mAST/ALT ratio was higher in severe cases.

Li J, Li S, Yang L, Cao P, Lu J. Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus. Crit Rev Microbiol. 2021;47(1):112–25. https://doi.org/10.1080/1040841X.2020.1847037.CrossRefPubMed

Wang L, Zou Z, Ding K, Hou C. Predictive risk score model for severe fever with thrombocytopenia syndrome mortality based on qSOFA and SIRS scoring system. BMC Infect Dis. 2020;20(1):595. https://doi.org/10.1186/s12879-020-05299-7.CrossRefPubMedPubMedCentral

Wang Y, Song Z, Wei X, Yuan H, Xu X, Liang H, et al. Clinical laboratory parameters and fatality of severe fever with thrombocytopenia syndrome patients: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2022;16(6):e0010489. https://doi.org/10.1371/journal.pntd.0010489.CrossRefPubMedPubMedCentral

Miyamoto S, Ito T, Terada S, Eguchi T, Furubeppu H, Kawamura H, et al. Fulminant myocarditis associated with severe fever with thrombocytopenia syndrome: a case report. BMC Infect Dis. 2019;19(1):266. https://doi.org/10.1186/s12879-019-3904-8.CrossRefPubMedPubMedCentral

Li S, Hu Q, Huang J, Wu X, Ren J. Mitochondria-Derived Damage-Associated molecular patterns in Sepsis: from bench to Bedside. Oxid Med Cell Longev. 2019;2019:6914849. https://doi.org/10.1155/2019/6914849.CrossRefPubMedPubMedCentral

Wu Y, Yao YM, Lu ZQ. Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure. J Mol Med (Berl). 2019;97(4):451–62. https://doi.org/10.1007/s00109-019-01756-2.CrossRefPubMed

Supinski GS, Schroder EA, Callahan LA, Mitochondria, Illness C. Chest. 2020;157(2):310–22. https://doi.org/10.1016/j.chest.2019.08.2182.CrossRefPubMed

Li S, Li H, Zhang YL, Xin QL, Guan ZQ, Chen X, et al. SFTSV infection induces BAK/BAX-Dependent mitochondrial DNA release to trigger NLRP3 inflammasome activation. Cell Rep. 2020;30(13):4370–4385e7. https://doi.org/10.1016/j.celrep.2020.02.105.CrossRefPubMed

Panteghini M. Aspartate aminotransferase isoenzymes. Clin Biochem. 1990;23(4):311–9. https://doi.org/10.1016/0009-9120(90)80062-n.CrossRefPubMed

10.

Otto-Ślusarczyk D, Graboń W, Mielczarek-Puta M. Aminotransferaza asparaginianowa–kluczowy enzym w metabolizmie ogólnoustrojowym człowieka [Aspartate aminotransferase–key enzyme in the human systemic metabolism]. Postepy Hig Med Dosw (Online). 2016;70:219–30. https://doi.org/10.5604/17322693.1197373. Polish. DOI.CrossRefPubMed

11.

Yang H, Zhou L, Shi Q, Zhao Y, Lin H, Zhang M, et al. SIRT3-dependent GOT2 acetylation status affects the malate-aspartate NADH shuttle activity and pancreatic tumor growth. EMBO J. 2015;34(8):1110–25. https://doi.org/10.15252/embj.201591041.CrossRefPubMedPubMedCentral

12.

Kamiike W, Fujikawa M, Koseki M, Sumimura J, Miyata M, Kawashima Y, et al. Different patterns of leakage of cytosolic and mitochondrial enzymes. Clin Chim Acta. 1989;185(3):265–70. https://doi.org/10.1016/0009-8981(89)90216-7.CrossRefPubMed

13.

Chen H, Wang C, Wei X, Ding X, Ying W. Malate-Aspartate Shuttle Inhibitor Aminooxyacetate Acid Induces Apoptosis and Impairs Energy Metabolism of Both Resting Microglia and LPS-Activated Microglia.Neurochem Res. 2015Jun;40(6):1311–8. doi: https://doi.org/10.1007/s11064-015-1589-y.

14.

Nishimura T, Yoshida Y, Watanabe F, Koseki M, Nishida T, Tagawa K, et al. Blood level of mitochondrial aspartate aminotransferase as an indicator of the extent of ischemic necrosis of the rat liver. Hepatology. 1986;6(4):701–7. https://doi.org/10.1002/hep.1840060427.CrossRefPubMed

15.

Huseby NE, Grøstad M, Almdahl SM, Vaage J. Activities of mitochondrial aspartate aminotransferase and creatine kinase isoenzyme MB in serum following coronary bypass surgery. Clin Chim Acta. 1990;195(1–2):1–7. https://doi.org/10.1016/0009-8981(90)90188-x.CrossRefPubMed

16.

Wang L, Xu Y, Zhang S, Bibi A, Xu Y, Li T. The AST/ALT ratio (De Ritis ratio) Represents an unfavorable prognosis in patients in early-stage SFTS: an Observational Cohort Study. Front Cell Infect Microbiol. 2022;12:725642. https://doi.org/10.3389/fcimb.2022.725642.CrossRefPubMedPubMedCentral

17.

World Health Organization. 2018. 2018 Annual review of diseases prioritized under the research and development blue-print. https://www.who.int/news-room/events/detail/2018/02/06/default-calendar/2018-annual-review-of-diseases-prioritized-under-the-research-anddevelopment-blueprint.

18.

Xu S, Jiang N, Nawaz W, Liu B, Zhang F, Liu Y, et al. Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome. PLoS Pathog. 2021;17(5):e1009587. https://doi.org/10.1371/journal.ppat.1009587.CrossRefPubMedPubMedCentral

19.

Kwon JS, Kim MC, Kim JY, Jeon NY, Ryu BH, Hong J, et al. Kinetics of viral load and cytokines in severe fever with thrombocytopenia syndrome. J Clin Virol. 2018;101:57–62. https://doi.org/10.1016/j.jcv.2018.01.017.CrossRefPubMedPubMedCentral

20.

Fajgenbaum DC, June CH, Cytokine Storm. N Engl J Med. 2020;383(23):2255–73. https://doi.org/10.1056/NEJMra2026131.CrossRefPubMedPubMedCentral

21.

Nalpas B, Vassault A, Charpin S, Lacour B, Berthelot P. Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit. Hepatology. 1986;608–14. https://doi.org/10.1002/hep.1840060410.

22.

Nakajima K, Yuno M, Tanaka K, Nakamura T. High aspartate Aminotransferase/Alanine aminotransferase ratio may be Associated with all-cause mortality in the Elderly: a Retrospective Cohort Study using Artificial Intelligence and Conventional Analysis. Healthc (Basel). 2022;10(4):674. https://doi.org/10.3390/healthcare10040674.CrossRef

23.

Li X, He W, Zhang X, Shu F, Liu Y, Tan N, Jiang L. Elevated α-hydroxybutyrate dehydrogenase is associated with in-hospital mortality in non-ischemic dilated cardiomyopathy. Front Cardiovasc Med. 2022;9:995899. https://doi.org/10.3389/fcvm.2022.995899.CrossRefPubMedPubMedCentral

24.

Limin Z, Alsamani R, Jianwei W, Yijun S, Dan W, Yuehong S, et al. The relationship of α-hydroxybutyrate dehydrogenase with 1-year outcomes in patients with intracerebral hemorrhage: a retrospective study. Front Neurol. 2022;13:906249. https://doi.org/10.3389/fneur.2022.906249.CrossRefPubMedPubMedCentral

25.

Liu Z, Li J, Li M, Chen S, Gao R, Zeng G, et al. Elevated α-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19. ESC Heart Fail. 2021;8(1):644–51. https://doi.org/10.1002/ehf2.13151.CrossRefPubMed

26.

Lin Y, Xu Y, Zhang Z. Sepsis-Induced Myocardial Dysfunction (SIMD): the pathophysiological mechanisms and therapeutic strategies targeting Mitochondria. Inflammation. 2020;43(4):1184–200. https://doi.org/10.1007/s10753-020-01233-w.CrossRefPubMed

27.

Fan J, Li Z, Yi L, Ding H, Zhao M, Fan S, et al. Viral infection modulates mitochondrial function. Int J Mol Sci. 2021;22(8):4260. https://doi.org/10.3390/ijms22084260.CrossRefPubMedPubMedCentral

28.

Supinski GS, Schroder EA, Callahan LA, Mitochondria, Illness C. Chest. 2020;157(2):310–22. https://doi.org/10.1016/j.chest.2019.08.2182.CrossRefPubMed

29.

Jiang X, Wang J, Chang H, Zhou Y. Recombinant expression, purification and crystallographic studies of the mature form of human mitochondrial aspartate aminotransferase. Biosci Trends. 2016 Feb;10(1):79–84. https://doi.org/10.5582/bst.2015.01150. Epub 2016 Feb 22. PMID: 26902786.

Title: Serum mAST/ALT ratio had high predictive value for adverse outcome of severe fever with thrombocytopenia syndrome with severe condition
Authors: Li Wang
Youde Liu
Renliang Qu
Zhiqiang Zou
Publication date: 01-12-2023
Publisher: BioMed Central
Keyword: Thrombocytopenia
Published in: BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-023-08121-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Evaluate prognostic accuracy of SOFA component score for mortality among adults with sepsis by machine learning method

Development and validation of a nomogram for predicting severe respiratory syncytial virus-associated bronchiolitis

Association between cyclin-dependent kinase inhibitor 2B antisense RNA 1 and zinc finger homeobox 3 gene polymorphisms and COVID-19 severity

Influence of COVID-19 pandemic on the virus spectrum in children with respiratory infection in Xuzhou, China: a long-term active surveillance study from 2015 to 2021

Seasonality of cholera in Kolkata and the influence of climate

Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials

Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT